Please see below for a list of search results.
HTA-licensed establishments in the post mortem sector are required to report incidents (HTARIs), and those in the human application and organ donation and transplantation sectors are required to report serious adverse events or reactions (SAEARs), as part of their licensing with us.
7 December 2015 update: The French Competent Authority issued an update to itsalert. The update noted that additional precautions taken in France following detection of this case of West Nile Virus in October 2015 were no longer in force.
Issued 27 November 2015
The HTA was asked to provide information relating to serious adverse events and adverse reactions (SAEARs) in the organ donation and transplantation sector in the year 2015.
Issued 2 November 2016
• Designated Individuals (DIs) in the Human Application (HA) sector • Licence contacts in the Organ Donation and Transplantation (ODT) sector
The following guidance has been produced to bring clarity to the issues surrounding consent under the Human Tissue Act 2004 for research relating to transplantation where donors are deceased. It applies in England, Wales and Northern Ireland, and is not affected by the Human Transplantation (...
The Human Tissue Authority (HTA), on behalf of Scottish Ministers, is responsible for assessing all living organ donation cases that take place in Scotland. The HTA also considers allogeneic donation of regenerative tissue where the donor is under 16 or an adult with incapacity in Scotland.
The Human Tissue Authority’s (HTA) role in living organ donation is to ensure that there has been no reward sought or offered for the organ donation and to provide an independent check to help protect the interests of living organ donors.